Hot Search
No search results found
- Write an article
- Post discussion
- Create a list
- Upload a video
In January 2013, Nick Taussig founded award-winning UK production outfit, Salon Pictures, with Paul Van Carter. Together they have produced Stardust (dir. Gabriel Range), Audrey (dir. Helena Coan), Killing Escobar (dir. David Whitney), McQueen (dir. Ian Bonhote & Peter Ettedgui), Churchill (dir. Jonathan Teplitzky), My Name Is Lenny (dir. Ron Scalpello), Lek & the Dogs (dir. Andrew Kotting), Chasing Perfect (dir. Helena Coan), Breaking Habits (dir. Rob Ryan), The Spy Who Fell To Earth (dir. Tom Meadmore), The Challenge (dir. Peter Williams), Gascoigne (dir. Jane Preston), The Iconoclast (dir. King Adz) and The Guv'nor (dir. Paul Van Carter). Nick has recently directed A Space in Time with Riccardo Servini, a feature documentary response to the diagnosis of his two sons, Theo and Oskar, with Duchenne muscular dystrophy, a fatal muscle wasting disease. Supported by the BFI, it will be released by Bohemia Media in May 2021. Prior to Salon, Nick headed up distribution at Revolver. He acquired, and oversaw the release of, some of the most important films of the last decade, including Alex Gibney's Oscar-winning doc Taxi to the Dark Side, Charlie Kaufman's Synecdoche, New York, Werner Herzog's Grizzly Man, Guillaume Canet's Tell No One, and Justin Kurzel's Snowtown. He also ran the production arm, producing four films with Paul Van Carter including Offender, Anuvahood, Shank and Sket. In addition, he is the author of four novels, his most recent, The Distinguished Assassin. Prior to his career in film, he studied literature and philosophy at Durham University, where he obtained a First, then went on to acquire a Master's in Russian literature from the UCL School of Slavonic and East European Studies. Nick is also co-founder of Mtaala Foundation, an education partnership and sponsorship programme to create and support a school for vulnerable children and at-risk youth in Uganda; and a trustee of Harrison's Fund, which fights Duchenne muscular dystrophy, getting as much money as possible into the hands of the world's best researchers, who are working to find a cure for this fatal genetic disease.